Site Management/Investigator Payments Featured Articles

  1. Why CRA Proficiency Needs A Boost From Better Assessment And Training 6/20/2025

    CRAs intend to fulfill clinical research’s commitment to patient safety. Yet, some fall short of true proficiency, and Gerald DeWolfe contends better evaluations and training can help.

  2. 5 Ways To Make Your Investigator Meetings Fun And Functional 6/17/2025

    Discover five ways CROs and sponsors can better engage and communicate with site staff for better relationships and better trials.

  3. Hidden Compliance Risks In Start-Up That Could Derail Your Clinical Trial 6/13/2025

    Kulkarni Law Firm Senior Attorney Edye T. Edens explores the risks embedded in clinical trial start-up activities, such as site activation, contract execution, delegation of responsibilities, and cross-border data flows.

  4. J&J Survey Of Oncologists Reveals Challenges With Awareness & Access 6/12/2025

    J&J President, U.S. Solid Tumor Biljana Naumovic discusses the company's Oncology Care Index, which revealed issues with oncology provider awareness of and access to clinical trials.

  5. Improving Recruitment Needs More Than Transactional Fixes To Earn Patient Trust 6/11/2025

    Driving patient recruitment and retention in clinical trials isn't always about scheduling, transportation, or even reimbursement. Often, and especially for marginalized communities, it begins with trust.

  6. U.S. Tariffs And Their Tenuous Impact On Clinical Trials 6/10/2025

    RSM US LLP Life Sciences Senior Analyst Amanda Laskey discusses Trump administration tariffs and how they're expected to impact the pharma world, specifically clinical research.

  7. When CRO Selection Went Sideways, Ashvattha Therapeutics Did This To Recover 6/6/2025

    Ashvattha Therapeutics CEO Jeff Cleland, Ph.D. shares a near-catastrophic CRO experience and explains how his team rebounded just in time.

  8. Nurturing Clinical Site Relationships Drives Trial Success 6/3/2025

    Whether a clinical trial is studying rare disease therapies or large-volume vaccines, three Ps define the approach to site feasibility: patients, product, and procedures. Advanced technological and methodological tools can assist sponsors, CROs, and sites in identifying fruitful collaborations, but person-to-person discussion and communication must drive those collaborations. 

  9. Inside The Trials Aiming To Stop Vision Loss For Rare Eye Disease Patients 5/27/2025

    Ocugen Chief Medical Officer Huma Qamar, MD, MPH, CMI, discusses two rare disease trials and how the company's managed their protocol design, PI selection, and patient recruitment.

  10. Spiders, Mold, & SOPs: Tales From A Site Inspection Veteran 5/22/2025

    Sarah Moeller, a veteran of mock regulatory inspections, shares lessons from over 300 site visits, emphasizing preparation, documentation, and patient-focused practices to ensure sites are inspection-ready.